Whitehawk Therapeutics (WHWK) Profit After Tax (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Profit After Tax of -$22.2 million for Q1 2026, down 130.4% year-over-year from $73.0 million in Q1 2025, and up 4.7% quarter-over-quarter from -$23.3 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Profit After Tax (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Profit After Tax data on file, last reported at -$22.2 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$22.2 million, down 130.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$115.9 million (down 519.83% YoY), and the FY2025 annual result was -$20.6 million, up 67.66% from the prior year.
- Profit After Tax rose to -$22.2 million in Q1 2026 per WHWK's latest filing, from -$23.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $73.0 million in Q1 2025 and troughed at -$52.6 million in Q2 2025.
- A 5-year average of -$13.7 million and a median of -$16.3 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax slumped 1089.39% in 2022, then soared 499.23% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$13.9 million in 2022, then fell by 16.91% to -$16.3 million in 2023, then declined by 12.46% to -$18.3 million in 2024, then slipped by 27.36% to -$23.3 million in 2025, then rose by 4.7% to -$22.2 million in 2026.
- Business Quant data shows WHWK's Profit After Tax at -$22.2 million in Q1 2026, -$23.3 million in Q4 2025, and -$17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | -22.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.20 Mn |
| Dec 31, 2025 | -23.30 Mn |
| Sep 30, 2025 | -17.75 Mn |
| Jun 30, 2025 | -52.62 Mn |
| Mar 31, 2025 | 73.02 Mn |
| Dec 31, 2024 | -18.29 Mn |
| Sep 30, 2024 | -12.55 Mn |
| Jun 30, 2024 | -14.58 Mn |
| Mar 31, 2024 | -18.29 Mn |
| Dec 31, 2023 | -16.27 Mn |
| Sep 30, 2023 | -16.30 Mn |
| Jun 30, 2023 | -17.97 Mn |
| Mar 31, 2023 | -15.22 Mn |
| Dec 31, 2022 | -13.91 Mn |
| Sep 30, 2022 | -14.50 Mn |
| Jun 30, 2022 | -18.27 Mn |
| Mar 31, 2022 | -13.86 Mn |
| Dec 31, 2021 | -15.99 Mn |
| Sep 30, 2021 | -87.09 Mn |
| Jun 30, 2021 | -1.54 Mn |